T-Cell Lymphoma Clinical Trials

A listing of T-Cell Lymphoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 186 clinical trials
Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma

The purpose of this study is to evaluate how safe and effective the combination of the study drugs romidepsin and lenalidomide is for treating patients with peripheral t-cell lymphoma (PTCL) who

revlimid
enteropathy
lymphoma
histone deacetylase inhibitor
intestinal t-cell lymphoma
  • 131 views
  • 24 Feb, 2020
  • 5 locations
Phase I/II Study Evaluating AUTO4 in Patients With TRBC1 Positive T Cell Lymphoma

The purpose of this study is to test the safety and efficacy of AUTO4 a CAR T cell treatment targeting TRBC1 in patients with relapsed or refractory TRBC1 positive selected T-Non-Hodgkin Lymphoma.

neutrophil count
lymphoma
t-cell lymphoma
peripheral t-cell lymphoma
anaplastic large cell lymphoma
  • 35 views
  • 04 Nov, 2020
  • 5 locations
A Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy

This study is to evaluate the objective response rate to pralatrexate in Asian PTCL patients after prior treatment failure, as determined by independent imaging reviewer(s) using international workshop lymphoma response criteria (IWC)

leukemia
adult t-cell leukemia
enteropathy
intestinal t-cell lymphoma
pralatrexate
  • 98 views
  • 08 Nov, 2020
Sintilimab and Decitabine for Patients With Relapsed/Refractory or Advanced NK/T-cell Lymphoma

The purpose of this study is to evaluate the efficacy and safety of Sintilimab in combination with decitabine in the treatment of Relapsed/Refractory or advanced NK/T-cell lymphoma patients

renal function
  • 0 views
  • 14 May, 2020
  • 1 location
Brentuximab Vedotin and Lenalidomide in Patients With Relapsed/ Refractory T-cell Lymphoma or Hodgkin Lymphoma

This study is investigating the combination of Brentuximab vedotin and lenalidomide in the treatment of relapsed/refractory peripheral T cell lymphoma or cutaneous T cell lymphoma or Hodgkin

lenalidomide
brentuximab vedotin
neutrophil count
cutaneous t-cell lymphoma
platelet count
  • 0 views
  • 07 Oct, 2020
  • 1 location
Nivolumab With Standard of Care Chemotherapy for Peripheral T Cell Lymphomas

This regimen aims to become the first line treatment for peripheral T cell lymphoma, using nivolumab with the standard of care chemotherapy.

warfarin
nivolumab
platelet count
enteropathy
prednisone
  • 10 views
  • 09 Sep, 2020
  • 3 locations
A Study to Assess the Feasibility of Romidepsin Combined With Brentuximab Vedotin in Cutaneous T-cell Lymphoma

This is a Phase I Trial to assess the feasibility of Romidepsin combined with Brentuximab Vedotin for patients requiring Systemic Therapy for Cutaneous T-cell Lymphoma.

neutrophil count
sezary syndrome
mycosis fungoides
cutaneous t-cell lymphoma
psoralen
  • 0 views
  • 25 Dec, 2020
  • 1 location
Compare Efficacy of CHOP Versus Fractionated ICED in Transplant-eligible Patients With Previously Untreated PTCL

This study is a Randomized Phase II Study to Compare Efficacy of CHOP versus Fractionated ICED in Transplant-eligible Patients with Previously Untreated Peripheral T-cell Lymphoma.

t-cell lymphoma
intestinal t-cell lymphoma
anaplastic large cell lymphoma
angioimmunoblastic t-cell lymphoma
large cell lymphoma
  • 10 views
  • 28 Oct, 2020
  • 1 location
A Study of PD-1/CTLA-4 Bispecific AK104 in Relapsed or Refractory Peripheral T-cell Lymphoma

The purpose of this study is to evaluate the efficacy and safety of AK104an anti- PD-1 and CTLA-4 bispecific antibody, in subjects with relapsed or refractory peripheral T cell lymphoma. The

refractory peripheral t-cell lymphoma
t-cell lymphoma
cancer
  • 0 views
  • 29 Jun, 2020
  • 1 location
Azacitidine Combined With Chidamide in the Treatment of Newly Diagnosed PTCL Unfit for Conventional Chemotherapy

This prospective, open-label, single-arm study will evaluate the efficacy and safety of azacitidine in combination with chidamide in treatment of newly diagnosed peripheral T-cell lymphoma unfit

t-cell lymphoma
chidamide
measurable disease
  • 0 views
  • 05 Aug, 2020
  • 1 location